Melanoma, Cutaneous Malignant, Susceptibility To, 9; Cmm9
Description
Malignant melanoma is a neoplasm of pigment-producing cells called melanocytes that occurs most often in the skin, but may also occur in the eyes, ears, gastrointestinal tract, leptomeninges, and oral and genital mucous membranes (summary by Habif, 2010).For a discussion of genetic heterogeneity of malignant melanoma, see {155600}.
Genes related to Melanoma, Cutaneous Malignant, Susceptibility To, 9; Cmm9
- TERT
Clinical Features
Phenotypes and symptoms related to Melanoma, Cutaneous Malignant, Susceptibility To, 9; Cmm9
- Neoplasm
- Carcinoma
- Melanoma
- Ovarian neoplasm
- Renal cell carcinoma
- Bladder neoplasm
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Melanoma, Cutaneous Malignant, Susceptibility To, 9; Cmm9 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Comprehensive Pulmonary Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RPGR, SCNN1A, SCNN1B, SCNN1G, BMPR1B, BMPR2, SFTPA1, SFTPA2, SFTPB, SFTPC, SFTPD, SLC7A7, SPAG1, STAT3, TERC, TERT, TINF2, NKX2-1, TSC1, TSC2 , (...)
View the complete list with 73 more genes
Specificity
2 %
Genes
100 % |
Hermansky-Pudlak and Pulmonary Fibrosis Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
SFTPA1, SFTPA2, SFTPB, SFTPC, SFTPD, TERC, TERT, TINF2, NKX2-1, HPS3, HPS4, RTEL1, HPS5, DTNBP1, HPS6, BLOC1S3, CSF2RA, ELMOD2, DKC1, ABCA3 , (...)
View the complete list with 5 more genes
Specificity
4 %
Genes
100 % |
Diffuse Lung Disease NGS Panel.
By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States).
SFTPA2, SFTPB, SFTPC, SLC7A7, TERC, TERT, TINF2, NKX2-1, HPS4, CSF2RA, CSF2RB, DKC1, ABCA3, FOXF1, HPS1, AP3B1
Specificity
7 %
Genes
100 % |
Telomere Shortening Disorders Spectrum NGS Panel.
By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States).
TERC, TERT, TINF2, NHP2, NOP10, WRAP53, CTC1, DKC1
Specificity
13 %
Genes
100 % |
Idiopathic Pulmonary Fibrosis NGS Panel.
By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States).
SFTPA2, SFTPC, TERC, TERT, TINF2, NKX2-1, HPS4, DKC1, ABCA3, HPS1, AP3B1
Specificity
10 %
Genes
100 % |
Bone Marrow Failure.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
RPL11, RPL35A, RPL5, RPS10, RPS15, RPS19, RPS24, RPS26, RPS27A, RPS7, BRCA2, SRP72, TERT, THPO, TINF2, XRCC2, RPL36, NHP2, NOP10, SBDS , (...)
View the complete list with 23 more genes
Specificity
3 %
Genes
100 % |
Bone Marrow Failure Syndromes Panel by next-generation sequencing (NGS).
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
RMRP, RPL11, RPL15, RPL26, RPL35A, RPL5, RPS10, RPS17, RPS19, RPS24, RPS26, RPS7, BRCA2, SRP72, TAZ, TERC, TERT, TINF2, WAS, WIPF1 , (...)
View the complete list with 40 more genes
Specificity
2 %
Genes
100 % |
Dyskeratosis Congenita panel by next-generation sequencing (NGS).
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
TERC, TERT, TINF2, NHP2, NOP10, RTEL1, WRAP53, DKC1
Specificity
13 %
Genes
100 % |
You can get up to 115 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like TRIGONOCEPHALY 1; TRIGNO1 REVESZ SYNDROME LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT; HOMG5 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N SPINOCEREBELLAR ATAXIA 23; SCA23 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37; MRT37